Skip to main content
. 2024 Mar 26;5(4):101473. doi: 10.1016/j.xcrm.2024.101473

Table 2.

Comparison of thyroid indicators between the two groups

Thyroid indicators Experimental group (n = 57)
Control group (n = 60)
p Value
Baseline 24 weeks P Baseline 24 weeks p Value
TSH (mIU/L) 6.23 (5.30, 7.92) 4.07 (2.56, 5.12) <0.001 6.72 (5.78, 7.63) 5.23 (3.26, 7.14) <0.001 0.008
FT3 (pg/mL) 2.64 (2.31, 3.02) 2.99 (2.73, 3.81) <0.001 2.47 (2.12, 3.13) 2.80 (2.51, 3.04) 0.039 0.014
FT4 (ng/dL) 1.20 (1.06, 1.34) 1.20 (1.09, 1.37) 0.404 1.13 (1.00, 1.30) 1.19 (1.02, 1.28) 0.845 0.163
TT3 (ng/mL) 0.92 (0.75, 1.12) 1.00 (0.91, 1.25) 0.005 0.85 (0.72, 1.03) 0.92 (0.82, 1.15) 0.010 0.093
TT4 (μg/dL) 7.90 (6.43, 8.68) 8.20 (7.30, 9.10) 0.109 6.80 (5.20,7.95) 7.35 (6.53, 8.58) 0.106 0.024
Grouping of TSH level (n [%])
 24-week TSH < 4.78 (mIU/L) 34 (73.9%) 22 (45.8%) 0.006
Risk ratio (95% CI) 1.613 (1.134, 2.294)
 24-week TSH > 10 mIU/L 0 1 (2.1%) 0.325

TSH, thyroid-stimulating hormone; FT3, free triiodothyronine; FT4, free thyroxine; TT3, triiodothyronine; TT4, thyroxine.